Year |
Citation |
Score |
2019 |
Tripathi M, Nandana S, Huang J, Kato M, Mishra R, Chung L, Xin L, Bhowmick N. Abstract 5164: Signaling crosstalk within prostate tumor microenvironment mediates castrate resistant disease progression Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-5164 |
0.345 |
|
2017 |
Debebe A, Medina V, Chen CY, Mahajan IM, Jia C, Fu D, He L, Zeng N, Stiles BW, Chen CL, Wang M, Aggarwal KR, Peng Z, Huang J, Chen J, et al. Wnt/β-catenin activation and macrophage induction during liver cancer development following steatosis. Oncogene. PMID 28671671 DOI: 10.1038/Onc.2017.207 |
0.345 |
|
2017 |
Wu JB, Yin L, Shi C, Li Q, Duan P, Huang JM, Liu C, Wang F, Lewis M, Wang Y, Lin TP, Pan CC, Posadas EM, Zhau HE, Chung LW. MAOA-Dependent Activation of Shh-IL6-RANKL Signaling Network Promotes Prostate Cancer Metastasis by Engaging Tumor-Stromal Cell Interactions. Cancer Cell. 31: 368-382. PMID 28292438 DOI: 10.1016/J.Ccell.2017.02.003 |
0.396 |
|
2016 |
Li Q, Yin L, Jones LW, Chu GC, Wu JB, Huang JM, Li Q, You S, Kim J, Lu YT, Mrdenovic S, Wang R, Freeman MR, Garraway I, Lewis MS, et al. Keratin 13 expression reprograms bone and brain metastases of human prostate cancer cells. Oncotarget. PMID 27835867 DOI: 10.18632/Oncotarget.13175 |
0.418 |
|
2016 |
Tripathi M, Nandana S, Huang J, Kato M, Chung LWK, Mishra R, Xin L, Bhowmick N. Abstract PR06: Reciprocal prostate cancer signaling with its microenvironment mediates castrate-resistant disease progression Cancer Research. 76. DOI: 10.1158/1538-7445.Tme16-Pr06 |
0.433 |
|
2016 |
Yin L, Li Q, Huang J, Lewis M, Garraway IP, Li Q, Bu H, Chung LWK, Zhau HE. Abstract 4957: Keratin 13 drives the dissemination of bone and brain metastases of human prostate and breast cancer cells Cancer Research. 76: 4957-4957. DOI: 10.1158/1538-7445.Am2016-4957 |
0.418 |
|
2016 |
Huang J, Chu GC, Kim HL, Zhau HE, LWKC. Abstract 1630: Dysregulation of Hippo pathway in metastatic prostate cancer Cancer Research. 76: 1630-1630. DOI: 10.1158/1538-7445.Am2016-1630 |
0.48 |
|
2015 |
Ziaee S, Chu GC, Huang JM, Sieh S, Chung LW. Prostate cancer metastasis: roles of recruitment and reprogramming, cell signal network and three-dimensional growth characteristics. Translational Andrology and Urology. 4: 438-54. PMID 26816842 DOI: 10.3978/J.Issn.2223-4683.2015.04.10 |
0.452 |
|
2015 |
Gururajan M, Cavassani KA, Sievert M, Duan P, Lichterman J, Huang JM, Smith B, You S, Nandana S, Chu GC, Mink S, Josson S, Liu C, Morello M, Jones LW, et al. SRC family kinase FYN promotes the neuroendocrine phenotype and visceral metastasis in advanced prostate cancer. Oncotarget. PMID 26624980 DOI: 10.18632/Oncotarget.6398 |
0.503 |
|
2015 |
Brun SN, Markant SL, Esparza LA, Garcia G, Terry D, Huang JM, Pavlyukov MS, Li XN, Grant GA, Crawford JR, Levy ML, Conway EM, Smith LH, Nakano I, Berezov A, et al. Survivin as a therapeutic target in Sonic hedgehog-driven medulloblastoma. Oncogene. 34: 3770-9. PMID 25241898 DOI: 10.1038/Onc.2014.304 |
0.433 |
|
2013 |
Huang J, Nagatomo I, Suzuki E, Mizuno T, Kumagai T, Berezov A, Zhang H, Karlan B, Greene MI, Wang Q. YAP modifies cancer cell sensitivity to EGFR and survivin inhibitors and is negatively regulated by the non-receptor type protein tyrosine phosphatase 14. Oncogene. 32: 2220-2229. PMID 22689061 DOI: 10.1038/Onc.2012.231 |
0.401 |
|
2010 |
Huang JM, Sheard MA, Ji L, Sposto R, Keshelava N. Combination of vorinostat and flavopiridol is selectively cytotoxic to multidrug-resistant neuroblastoma cell lines with mutant TP53. Molecular Cancer Therapeutics. 9: 3289-301. PMID 21159612 DOI: 10.1158/1535-7163.Mct-10-0562 |
0.429 |
|
2004 |
Hong M, Luo S, Baumeister P, Huang JM, Gogia RK, Li M, Lee AS. Underglycosylation of ATF6 as a novel sensing mechanism for activation of the unfolded protein response. The Journal of Biological Chemistry. 279: 11354-63. PMID 14699159 DOI: 10.1074/Jbc.M309804200 |
0.314 |
|
2003 |
Huang JM, Lin TY, Chang D, Lin SL, Ying SY. Truncated Bcl-2, a potential pre-metastatic marker in prostate cancer. Biochemical and Biophysical Research Communications. 306: 912-7. PMID 12821128 DOI: 10.1016/S0006-291X(03)01072-6 |
0.317 |
|
Show low-probability matches. |